We Are Investigating Claims in Indiana and New Mexico for Diabetes Medicines Invokana, Invokamet, and Other SGLT2 Inhibitors

The attorneys at Keller & Keller are currently investigating potential claims on behalf of patients who have suffered serious injuries after taking the type 2 diabetes drug, Invokana (canagliflozin), and are accepting clients in both Indiana and New Mexico. If you or a loved one has been diagnosed with, or hospitalized for, ketoacidosis, myocardial infarction (heart attack), or kidney failure after being treated with Invokana, please contact the defective drug team at Keller & Keller right away. Do not change or stop taking your diabetes medicine without first consulting your doctor.

What is Invokana?

Invokana was approved by the FDA in 2013 as a medication to treat type 2 diabetes. Invokana belongs to a class of medications known as sodium-glucose cotransporter-2 (SGLT2) inhibitors, which have been FDA approved to lower blood sugar in adults with type 2 diabetes. Invokana is used in combination with diet and exercise and works to control blood sugar levels by blocking a natural enzyme in the body, therefore stopping some kidney functions and increasing the amount of sugar removed in the urine.

What are the Dangers of Invokana

Both the FDA and the Institute for Safe Medication Practices have released warnings about serious potential side effects, problems and risks caused by the use of Invokana. These include:‚Äč

  • Ketoacidosis: occurs when high levels of ketones are produced in the body. Ketoacidosis develops when the body is unable to produce enough insulin and the body therefore goes into emergency recovery mode. Left untreated, this condition can result in diabetic coma, extended hospitalization and even death.
 

The FDA’s 2015 Warning About Invokana & other SGLT2 Inhibitor Drugs

In May 2015, the FDA issued a Public Health Advisory for all drugs in the SGLT2 inhibitor class, including Invokana. An alarming number of FDA Adverse Event Reports have linked this drug to kidney failure. A review of the adverse event data shows that patients taking Invokana are several times more likely to report kidney failure than those taking non-SGLT2 diabetes drugs for type 2 diabetes. Left untreated, diabetic ketoacidosis can lead to loss of consciousness and could eventually be fatal.

In its safety announcement, the FDA stated that patients taking Invokana should pay close attention for any signs of ketoacidosis and seek medical attention immediately if they experience symptoms such as:

  • Difficulty breathing
  • Nausea
  • Vomiting
  • Abdominal pain
  • Confusion
  • Unusual fatigue or sleepiness
 

The Institute of Safe Medication Practices (ISMP) Issued a Warning About Invokana as Well:

The May 6th, 2015 edition of the ISMP’s Quarter Watch warns of a number of adverse reactions being reported from patient use of Invokana. In the 1st year after Invokana’s release, over 450 serious adverse event reports were filed. Many of these reports were related to renal toxicity. ISMP points out that at the time of FDA approval of Invokana in 2013, there had not been enough drug testing to answer the question of whether or not the clinical benefits of Invokana outweighed its risks.

Which Drugs Are Included in the Keller & Keller Investigation?

The SGLT2 class of drugs include:

  • Invokana
  • Invokamet
  • Farxiga
  • Xigduo XR
  • Jardiance
  • Glyxambi
 

The Reason for taking a closer look at Invokana

The Invokana investigation considers that the manufacturers and marketers—Mitsubishi Tanabe Pharmaceutical Corporation, Janssen Pharmaceuticals, and Johnson & Johnson—of SGLT2 inhibitors may have failed to adequately warn patients and physicians that taking Invokana increases the risks of  Ketoacidosis. 

When to Seek Medical Attention

If you are currently taking Invokana or another SGLT2 inhibitor, you should seek immediate attention if you have signs of any of the above conditions or if you experience symptoms such as chest pain, dizziness, faintness, increased heart rate, increased pulmonary rate, difficulty breathing, hyperventilation, weakness, changes in urination, anorexia, nausea, vomiting, abdominal pain, confusion, lethargy and unusual fatigue or sleepiness. Do not change or stop taking your diabetes medicine without first consulting with your doctor.

Learn More About Invokana Side Effects Here

When to Contact a Lawyer

If you or a loved one has suffered from kidney failure, heart attack, stroke, diabetic ketoacidosis, or wrongful death it is important to contact an attorney immediately due to state laws which limit the amount of time you have in which to file a case. If a claim is not filed before the statute of limitations expires, you are forever barred from bringing a claim against the liable parties.

Why You Should Hire Keller & Keller

Since 1936, Keller & Keller has been protecting the rights of injured people, including those harmed by multi-billion dollar pharmaceutical companies. Our founder, George Keller, was a pioneer in the field of wrongful death, and our firm has continued to practice law in accordance with his well-known approach of providing clients with aggressive, no-nonsense legal representation.